Natco Pharma Usa

Natco Pharma USA (formerly DASH Pharmaceuticals) is the U.S. subsidiary of Natco Pharma Limited, a global leader in specialty generics. We focus on developing, manufacturing, and marketing generic finished dosage formulations (FDFs) and active pharmaceutical ingredients (APIs), with a strong emphasis on niche therapeutic areas and complex products. Our mission is simple yet powerful: to expand access to high-quality, affordable medicines while ensuring reliability in supply and exceptional customer service. Building our U.S. presence: Based in New Jersey, Natco Pharma USA is actively building the company’s U.S. operations—expanding commercial, supply chain and customer-facing capabilities, and serving as Natco’s front-end for the U.S. market to support future pipeline launches. As a trusted partner to some of the world’s largest generic pharmaceutical companies, Natco Pharma Limited, has played a key role in bringing several first-to-market generics and complex products to the U.S, including: Oseltamivir Capsules Lapatinib Tablets Everolimus Tablets Glatiramer Acetate Pre-Filled Syringes Liposomal Doxorubicin Vials With a strong pipeline and a commitment to innovation, Natco Pharma USA continues to deliver value to patients, providers, and partners across the US healthcare ecosystem.